[1]
SARANNYA RAVI, LIYA ROSLIN JOSEPH, and SREELAKSHMI VENUGOPAL, “COST ANALYSIS OF BRANDED VERSUS GENERIC ANTI-DIABETIC DRUGS USED FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN A TERTIARY CARE HOSPITAL”, Asian J Pharm Clin Res, vol. 17, no. 9, pp. 78–81, Sep. 2024.